Access the full text.
Sign up today, get DeepDyve free for 14 days.
P. Terasaki, D. Gjertson, J. Cecka, S. Takemoto (1996)
Fit and match hypothesis for kidney transplantation.Transplantation, 62 4
P. Beatty, M. Mori, E. Milford (1995)
Impact of racial genetic polymorphism on the probability of finding an HLA-matched donor.Transplantation, 60
P. Terasaki, D. Bernoco, M. Park, G. Ozturk, Y. Iwaki (1978)
Microdroplet testing for HLA-A, -B, -C, and -D antigens. The Phillip Levine Award Lecture.American journal of clinical pathology, 69 2
P. Terasaki, J. Cecka, D. Gjertson, S. Takemoto (1995)
High survival rates of kidney transplants from spousal and living unrelated donors.The New England journal of medicine, 333 6
Harper Am, Rosen Jd (1996)
The UNOS OPTN waiting list and donor registry.Clinical Transplantation
M. Schnitzler, Christopher Hollenbeak, David Cohen, Robert Woodward, J. Lowell, G. Singer, Raymond Tesi, Todd Howard, Thalachallour Mohanakumar, Daniel Brennan (1999)
The economic implications of HLA matching in cadaveric renal transplantation.The New England journal of medicine, 341 19
Y. Hata, Cecka Jm, S. Takemoto, M. Ozawa, Y. Cho, P. Terasaki (1998)
Effects of changes in the criteria for nationally shared kidney transplants for HLA-matched patients.Transplantation, 65 2
H. Takiff, D. Cook, N. Himaya, M. Mickey, P. Terasaki (1988)
DOMINANT EFFECT OF HISTOCOMPATIBILITY ON TEN‐YEAR KIDNEY TRANSPLANT SURVIVALTransplantation, 45
R. Kerman, P. Kimball, C. Buren, R. Lewis, B. Kahan (1991)
Stronger immune responsiveness of blacks vs whites may account for renal allograft survival differences.Transplantation proceedings, 23 1 Pt 1
F. Cosio, M. Falkenhain, T. Pesavento, M. Henry, E. Elkhammas, E. Davies, G. Bumgardner, R. Ferguson (1997)
Relationships between arterial hypertension and renal allograft survival in African-American patients.American journal of kidney diseases : the official journal of the National Kidney Foundation, 29 3
D. Gjertson (1996)
A multi-factor analysis of kidney graft outcomes at one and five years posttransplantation: 1996 UNOS Update.Clinical transplants
R. Patel, P. Terasaki (1969)
Significance of the positive crossmatch test in kidney transplantation.The New England journal of medicine, 280 14
J. Neylan (1998)
Effect of race and immunosuppression in renal transplantation: three-year survival results from a US multicenter, randomized trial. FK506 Kidney Transplant Study Group.Transplantation proceedings, 30 4
P. Held, B. Kahan, L. Hunsicker, David Liska, R. Wolfe, F. Port, D. Gaylin, Jose Garcia, L. Agodoa, H. Krakauer (1994)
The impact of HLA mismatches on the survival of first cadaveric kidney transplants.The New England journal of medicine, 331 12
S. Takemoto, P. Terasaki, J. Cecka, Y. Cho, D. Gjertson (1992)
Survival of nationally shared, HLA-matched kidney transplants from cadaveric donors. The UNOS Scientific Renal Transplant Registry.The New England journal of medicine, 327 12
H. Kauffman, L. Bennett, M. McBride, M. Ellison (1997)
The expanded donorTransplantation Reviews, 11
BackgroundIn October 1987, the United Network for Organ Sharing (UNOS) established a national kidney-sharing program to increase the number of HLA-matched transplantations. Since then, over 7500 cadaveric kidneys have been shipped to centers in 48 states for transplantation to HLA-matched patients. We evaluated the efficacy of the program during its first 12 years of operation.MethodsWe compared the rates of rejection and actuarial graft survival for 7614 HLA-matched and 81,364 HLA-mismatched cadaveric kidney transplantations reported to the UNOS Scientific Registry between October 1987 and September 1999. To assess the effects of the extended period of ischemia associated with shipping HLA-matched kidneys, we identified 3562 pairs of cadaveric kidneys in which one kidney went to an HLA-matched recipient and the other went to an HLA-mismatched recipient.ResultsThe estimated 10-year rate of graft survival was 52 percent for HLA-matched transplants, as compared with 37 percent for HLA-mismatched transplants. The estimated half-lives of the transplants were 12.5 years and 8.6 years, respectively, and the mean duration of cold ischemia was 23 hours and 22 hours, respectively. After adjustment for the effects of demographic characteristics, at 10 years the overall rates of graft survival and the rates of functional-graft survival (with data censored on patients who died with a functioning graft) were 10 percent and 11 percent higher, respectively, for HLA-matched transplants than for HLA-mismatched transplants. Among 3562 pairs of kidneys, HLA-matched transplants had higher rates of survival, a lower incidence of episodes of rejection, and a lower risk of loss as a result of rejection.ConclusionsA superior graft outcome with little increase in the duration of cold ischemia justifies national sharing of HLA-matched kidney transplants.
The New England Journal of Medicine – The New England Journal of Medicine
Published: Oct 12, 2000
Read and print from thousands of top scholarly journals.
Already have an account? Log in
Bookmark this article. You can see your Bookmarks on your DeepDyve Library.
To save an article, log in first, or sign up for a DeepDyve account if you don’t already have one.
Copy and paste the desired citation format or use the link below to download a file formatted for EndNote
Access the full text.
Sign up today, get DeepDyve free for 14 days.
All DeepDyve websites use cookies to improve your online experience. They were placed on your computer when you launched this website. You can change your cookie settings through your browser.